Project Grant HT9425261E115
Award Date 5/1/26
Completion Date 4/30/30
Dollars Obligated $600K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $1.25M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with a performance period through September 29, 2029. The award supports research investigating the structure, function, and inhibition of ONECUT2 as a driver of prostate cancer. This research initiative aligns with the DHA's broader portfolio of biomedical...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $501,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 15, 2025, with a completion date of July 14, 2027. The research project, titled "Large Oncosomes as Drivers of Prostate Cancer Bone Metastasis," is being conducted at the institution's West Hollywood, California location. This award supports biomedical...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $997,343 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year period beginning September 1, 2025, and concluding August 31, 2028. The award supports a multidimensional imaging data-driven approach for phenotyping multiple sclerosis, representing a translational research initiative aligned with the DHA's mission to advance innovative...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $839,537 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2026 through April 30, 2028. The award supports targeted base editing research designed to alleviate disease pathology in patients with C9ORF72 gene-associated amyotrophic lateral sclerosis (ALS). This represents a two-year initiative to advance therapeutic development and...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $6.15 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2028. The award supports therapeutic development of noncoding RNA drug TY1 for scleroderma treatment, representing translational research aimed at advancing innovative medical solutions for this connective tissue disease. Work will...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $974,043 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with an award date of September 1, 2025, and a completion date of August 31, 2029. The award funds research titled "Early Cardiac Biomarkers of Inflammation and Remodeling in DMD" (Duchenne muscular dystrophy), to be conducted at the medical center's West Hollywood, California...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $113,340 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 15, 2025 through August 14, 2028. The award supports research on ex vivo preservation techniques for vascularized composite allotransplantation (VCA) with a specific focus on developing tolerance induction protocols suitable for clinical application. This research...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $2.67M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2025 through May 31, 2029. The project, titled "Identifying Pathways of Progression of Acute Pancreatitis to Recurring Acute Pancreatitis and Chronic Pancreatitis," represents a four-year research initiative focused on understanding the disease progression...
- This Project Grant award, totaling $2,685,519.00, was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center in West Hollywood, CA. The grant supports advanced biomedical research to define human correlates of super-evasive disseminated tumor cells, assess their pathological relevance, and explore methods to eradicate them. This 4-year research project, running from July 1, 2025 to June 30, 2029, aims to...
- The Defense Health Agency awarded a $598,130 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. Specifically, the project will investigate the "Determinants of Lung Cancer-Associated Cachexia" over the period from February 15, 2025 to February 14, 2027. As a leading research...